PTN Key Stats
|Revenue (Quarterly YoY Growth)||-42.96%|
|EPS Diluted (TTM)||-0.4905|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||-23.40M|
|Gross Profit Margin (Quarterly)|
|Profit Margin (Quarterly)||-25567%|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM) Pro||Go Pro|
- Palatin Technologies To Participate In The 25th Annual Piper Jaffray Healthcare Conference PR Newswire Dec 2
- Palatin Technologies, Inc. and PHT Corporation to Present on Best Practices in Female Sexual Dysfunction (FSD) Clinical Study Design at Managing eCOA Data Summit Business Wire Nov 25
- Palatin Technologies' CEO Discusses F1Q 2014 Results - Earnings Call Transcript Seeking Alpha Nov 14
- Palatin Technologies Announces Option for License to Bremelanotide in Europe noodls Nov 14
- Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on November 14, 2013 noodls Nov 14
- Palatin Technologies Earnings Call scheduled for 10:00 am ET today Nov 14
- Palatin Technologies, Inc Discusses Q1 2014 Results (Webcast) Seeking Alpha Nov 14
- PALATIN TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Nov 14
- Palatin Technologies, Inc. (PTN) Post Slightly Smaller Q1 Loss Street Insider Nov 14
- Palatin Technologies Reports Successful Completion Of Device Bioequivalence Trial noodls Oct 28
PTN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Palatin Technologies is up 11.25% over the last year vs S&P 500 Total Return up 29.87%, SurModics up 20.04%, and Agilent Technologies up 47.92%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for PTN
Pro Strategies Featuring PTN
Did Palatin Technologies make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Palatin Technologies, Inc., is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.